Response by Lakireddy et al to Letters Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial"

Affiliations

¹ Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS (D.L.).
² Tufts Medical Center, Boston, MA (D.T.).
³ Inselspital, University of Bern, Switzerland (S.W).

Comment

Dhanunjaya Lakkireddy et al. Circulation. 2022.

. 2022 Apr 26;145(17):e850-e851.

doi: 10.1161/CIRCULATIONAHA.122.059423. Epub 2022 Apr 25.

¹ Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS (D.L.).
² Tufts Medical Center, Boston, MA (D.T.).
³ Inselspital, University of Bern, Switzerland (S.W).

No abstract available

Comment on

Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
Dhruva SS, Redberg RF. Dhruva SS, et al. Circulation. 2022 Apr 26;145(17):e845-e846. doi: 10.1161/CIRCULATIONAHA.121.057472. Epub 2022 Apr 25. Circulation. 2022. PMID: 35467950 No abstract available.
Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
Price MJ, Gibson DN, Kar S. Price MJ, et al. Circulation. 2022 Apr 26;145(17):e849. doi: 10.1161/CIRCULATIONAHA.121.058485. Epub 2022 Apr 25. Circulation. 2022. PMID: 35467951 No abstract available.
Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
Natale A, Kar S, Holmes D. Natale A, et al. Circulation. 2022 Apr 26;145(17):e847-e848. doi: 10.1161/CIRCULATIONAHA.121.057567. Epub 2022 Apr 25. Circulation. 2022. PMID: 35467955 No abstract available.